###### Significance of this study

What is already known about this subject?
=========================================

-   Reduction of muscle mass and strength is an important treatment target for patients with type 2 diabetes.

-   High-intensity resistance training improves physical function.

-   Radio calisthenics, which is a Japanese traditional exercise, are simple exercises that can be performed regardless of age and can move the muscles and joints effectively.

What are the new findings?
==========================

-   Skeletal muscle mass index (SMI, kg/m^2^) and lean body mass decreased in non-radio calisthenics exercisers during hospitalization.

-   The decrease of SMI was significantly lesser in radio calisthenics exercisers than in non-exercisers.

How might these results change the focus of research or clinical practice?
==========================================================================

-   Radio calisthenics are useful for maintaining skeletal muscle mass in patients with type 2 diabetes without adverse effects.

Introduction {#s1}
============

The number of patients with type 2 diabetes has been rapidly increasing, and these patients often suffer from a reduction of muscle mass and strength.[@R1] The reduction of muscle volume and weakness of muscle tissues with ageing is called sarcopenia, which often leads to motor function disorders, falls, fractures, and difficulty in participating in activities of daily life.[@R2] The presence of sarcopenia also increases the risk of chronic heart failure,[@R3] cardiovascular disease,[@R4] pneumonia,[@R5] and mortality.[@R6]

To maintain the human body's muscle volume, prolonged resistance training is required.[@R7] Moreover, exercise can raise the efficiency of muscular glucose uptake because of an increase in muscle forkhead box protein O1[@R8] and glucose transporter 4,[@R9] which controls blood glucose levels.[@R10] These rules are also applicable to patients with type 2 diabetes.[@R9] Recent studies have reported that high-intensity resistance training improves physical function and balance[@R11] and reduces the fear of falling.[@R14] The American College of Sports Medicine and the American Diabetes Association demonstrated that resistance training enhanced the skeletal muscle volume and recommended a combination of aerobic and resistance training for controlling blood glucose levels.[@R9] However, about half of the patients with diabetes did not perform the exercise regularly and a main reason for this was lack of time to exercise.[@R10]

In Japan, we habitually practice a Japanese traditional exercise called 'radio calisthenics'. These are simple exercises that can be performed regardless of age and can move the muscles and joints effectively according to the rhythm of the radio. It is considered a therapeutic exercise to promote health in Japan. The required time for calisthenics is approximately 3 min, and it has an exercise intensity of 4--4.5 metabolic equivalents (METs).[@R15] Radio calisthenics require a moderate-intensity aerobic activity that is considered to be suitable for the training of patients with type 2 diabetes. However, no studies have investigated the efficacy of radio calisthenics in patients with type 2 diabetes so far.

In addition, we have observed the reduction of muscle volume in patients with type 2 diabetes without prior physical inactivity during hospitalization for controlling blood glucose levels. Here, we investigated the efficacy of radio calisthenics for muscle mass in patients with type 2 diabetes in this retrospective cohort study.

Materials and methods {#s2}
=====================

Study patients {#s2-1}
--------------

We enrolled 42 patients with type 2 diabetes without physical inactivity who were all inpatients at the Kyoto Prefectural University of Medicine from April 2016 to March 2017. In this retrospective cohort study, 15 patients (11 men and 4 women), who were hospitalized from September 2016 to March 2017, practiced the radio calisthenics.

Lifestyle factors and medications {#s2-2}
---------------------------------

We administered a standardized questionnaire to all patients at the beginning of hospitalization. Patients were divided into non-smokers, ex-smokers, and current smokers. In addition, patients recorded the kinds and frequencies of their participation in sports or recreational activities in the questionnaire.[@R16] We categorized patients who performed any kind of sports regularly at least once a week as regular exercisers.[@R17] In addition, patients recorded the presence of drinking habits and insulin use on the questionnaire.

Data collection {#s2-3}
---------------

At the beginning of hospitalization, patients underwent an examination of the concentrations of several factors in venous blood, including fasting plasma glucose, creatinine, and C-peptide after an overnight fast. Hemoglobin A1c (HbA1c) was measured using high-performance liquid chromatography, and results were expressed as a National Glycohemoglobin Standardization Program unit. We used the Japanese Society of Nephrology equation for estimated glomerular filtration rate (eGFR): eGFR (mL/min/1.73 m^2^)=194×serum creatinine^−1.094^×age^−0.287^ (×0.739 for women).[@R18]

Body composition of patients was evaluated using the body composition analyzer with a multifrequency impedance called InBody 720 (InBody Japan, Tokyo, Japan).[@R19] The multifrequency impedance analyzer provided results that showed a good correlation with those obtained using the dual-energy X-ray absorptiometry method.[@R21] We collected data of body weight (BW, kg), skeletal muscle mass (kg), appendicular muscle mass (kg), and body fat mass (kg). Then, skeletal muscle mass index (SMI, kg/m^2^) was calculated by dividing the appendicular muscle mass (kg) by the square of the height (m).[@R22] Weight-adjusted SMI was derived by dividing skeletal muscle mass (kg) by the BW (kg). Body mass index was defined as BW (kg) by dividing the square of the height (m). We investigated the body composition twice, once at the beginning and then at the end of hospitalization, and analyzed the difference between the values at two points. We defined the change of SMI as the difference of SMI between the beginning and end of the hospitalization. We also defined decreased SMI as a change of SMI of \<0 kg/m^2^.

Retinopathy was assessed by chart review and graded as follows: no diabetic retinopathy, simple diabetic retinopathy, and proliferative diabetic retinopathy.[@R23] Neuropathy was diagnosed using criteria for diabetic neuropathy proposed by the Diagnostic Neuropathy Study Group.[@R24] Nephropathy was graded as follows: normoalbuminuria, urinary albumin excretion \<30 mg/g of creatinine (Cr) (mg/gCr); microalbuminuria, 30--300 mg/gCr; and macroalbuminuria, \>300 mg/gCr.[@R25]

Performance of radio calisthenics {#s2-4}
---------------------------------

Radio calisthenics were established for improving people's physical strength and promoting public health by Japan post in the 1950s and have been popular among many people regardless of age or sex in Japan. Radio calisthenics have two types: the first radio calisthenics involves moving muscles and joints of the whole body to the rhythm, and the second radio calisthenics is aimed to improve muscle strength. We adopted the second radio calisthenics in this study. The required time for the calisthenics is approximately 3 min, and it has an exercise intensity of 4.5 METs.

The duration of hospitalization was approximately 14 days, and we instructed the patients to perform the second radio calisthenics twice daily, once before breakfast and once after dinner on the bedside, during hospitalization. The training scheme of radio calisthenics was in accordance with a movie on DVD. We did not instruct any resistance training other than the radio calisthenics and aerobic training, mainly fast walking, for a total of 60 min/day.[@R26]

Meals during hospitalization {#s2-5}
----------------------------

The meals served to the hospitalized patients were set as follows: total energy was calculated as ideal BW×25--30 kcal/kg BW/day; carbohydrates comprised 50%--60% of the total energy; protein 1.0--1.2 g/kg BW/day; and the rest as fat, according to the recommendations of the Japanese Diabetes Society on dietetic therapy in Japanese patients with diabetes.[@R27] Moreover, patients were not allowed to take snacks or supplements other than the meals served during hospitalization.

Statistical analysis {#s2-6}
--------------------

Statistical analyses were performed using JMP V.12.0 software (SAS Institute, Cary, North Carolina). A p value of \<0.05 was considered statistically significant. The means or frequencies of potential confounding variables were calculated. Continuous variables were presented as mean±SD. Categorical variables were presented as numbers (percentage, %). P values were analyzed using the Mann-Whitney U test for continuous variables, and χ^2^ test for categorical variables was employed to assess the statistical significance of differences between the groups. Moreover, a paired t-test was performed to assess the statistical significance of differences between the beginning and end of the hospitalization. Then, we also analyzed the difference of change in SMI of patients with and without radio calisthenics according to the having exercise habit or not.

Results {#s3}
=======

Clinical characteristics of the 42 patients (24 men and 18 women) who participated in the survey are shown in [table 1](#T1){ref-type="table"}.

###### 

Characteristics of patients at the beginning of hospitalization

                                               Radio calisthenics (−)         Radio calisthenics (+)       P value
  -------------------------------------------- ------------------------------ ---------------------------- ---------
  Total number                                 27                             15                           --
  Male                                         13 (48.1)                      11 (73.3)                    0.11
  Age (years)                                  65.8±12.6                      62.9±14.5                    0.50
  Weight (kg)                                  64.1±16.3                      70.8±19.4                    0.24
  Body mass index (kg/m^2^)                    24.6±4.8                       26.4±7.9                     0.37
  Diabetes duration (years)                    14.5±9.0                       12.2±8.5                     0.44
  HbA1c (%)                                    9.3±1.8                        10.2±1.2                     0.10
  HbA1c (mmol/mol)                             77.8±19.4                      87.8±13.1                    0.10
  FBS (mg/dL)                                  167.7±51.5                     156.3±32.3                   0.44
  C-peptide (nmol/L)                           1.4±0.8                        1.7±1.4                      0.29
  Creatinine (mg/dL)                           0.73±0.2                       0.77±0.2                     0.63
  eGFR (mL/min/1.73 m²)                        77.8±23.5                      80.5±27.2                    0.74
  SMI (kg/m^2^)                                6.8±1.1                        7.1±1.4                      0.92
  Weight-adjusted SMI                          0.587±0.080                    0.572±0.096                  0.61
  Lean body mass (kg)                          23.3±5.3                       25.2±6.8                     0.32
  Right arm (kg)                               2.3±0.6                        2.4±0.9                      0.51
  Left arm (kg)                                2.2±0.6                        2.4±0.9                      0.40
  Trunk (kg)                                   19.4±4.1                       20.6±5.4                     0.42
  Right leg (kg)                               6.6±1.6                        7.3±2.1                      0.26
  Left leg (kg)                                6.6±1.6                        7.3±2.0                      0.20
  Body fat mass (kg)                           20.4±9.9                       23.7±13.3                    0.38
  Drinking habits                              13 (48.1)                      2 (13.3)                     0.96
  Smoking states                                                                                           0.96
   ‌‍Ex-smoker                                 9 (33.3)                       6 (40)                       
   Current smoker                              7 (25.9)                       2 (13.3)                     
  Exercise habits                              5 (18.5)                       2 (13.3)                     0.65
  Insulin treatments                           8 (29.6)                       4 (26.7)                     0.35
  Retinopathy (NDR/SDR/PDR)                    19 (70.4)/5 (18.5)/3 (11.1)    8 (53.3)/3 (20.0)/4 (13.7)   0.20
  Nephropathy (normo/micro/macroalbuminuria)   12 (44.4)/12 (44.4)/3 (11.1)   10 (66.7)/2 (13.3)/3 (20)    0.12
  Neuropathy                                   12 (44.4)/13 (48.1)            6 (40)/9 (60)                0.62

Data are expressed as n (%) or mean±SD. Weight-adjusted SMI was defined as dividing skeletal muscle mass by the body weight. P values by Welch's t-test for continuous variables and χ^2^ test for categorical variables.

eGFR, estimated glomerular filtration rate; FBS, fasting blood sugar; NDR, no diabetic retinopathy; PDR, proliferative diabetic retinopathy; SDR, simple diabetic retinopathy; SMI, skeletal muscle mass index.

Among them, 15 (11 men and 4 women) performed radio calisthenics during hospitalization. The average age of patients who did not exercise and those who exercised was 65.8±12.6 and 62.9±14.5 years, respectively. HbA1c levels in patients who did not exercise and in those who exercised were 9.3%±1.8% and 10.2%±1.2%, respectively. Every night during hospitalization, we asked the patients whether they had performed the radio calisthenics, and we confirmed that all of them have certainly done it twice a day.

The change of SMI (kg/m^2^) is shown in [figure 1](#F1){ref-type="fig"} and [table 2](#T2){ref-type="table"}. BWs of both non-radio calisthenics exercisers and radio calisthenics exercisers decreased during hospitalization, whereas SMI and lean body mass decreased in non-radio calisthenics exercisers but not in radio calisthenics exercisers during hospitalization. The change of SMI was significantly lesser in radio calisthenics exercisers than in non-radio calisthenics exercisers (−0.01±0.00 vs −0.27±0.06 kg/m^2^, p=0.016). The proportion of decreased SMI was 85.2% (23/27 patients) in non-radio calisthenics exercisers, whereas that in radio calisthenics exercisers was 46.7% (7/15 patients). Moreover, weights of appendicular skeletal and upper limb muscles significantly increased in radio calisthenics exercisers compared with those in non-radio calisthenics exercisers. In contrast, weight reduction of the lower limb muscles tended to be lesser in the radio calisthenics exercisers than in non-radio calisthenics exercisers. Fat content in the radio calisthenics exercisers was significantly decreased compared with non- radio calisthenics exercisers ([table 2](#T2){ref-type="table"}).

![Change of SMI between (A) non-radio calisthenics exercisers and (B) radio calisthenics exercisers and during the hospitalization. SMI, skeletal muscle mass index.](bmjdrc-2019-001027f01){#F1}

###### 

Characteristics of patients at the beginning and end of hospitalization

                              Radio calisthenics (−)   Radio calisthenics (+)                                                                         
  --------------------------- ------------------------ ------------------------ ------------ --------- ----------- ----------- ------------ --------- -------
  Weight (kg)                 64.1±16.3                62.4±15.2                −1.66±0.40   \<0.001   70.8±19.4   69.2±18.0   −1.55±0.53   0.030     0.861
  Body mass index (kg/m^2^)   24.6±4.8                 24.1±4.5                 −0.62±0.13   \<0.001   26.4±7.9    25.8±7.5    −0.56±0.18   0.021     0.789
  SMI (kg/m^2^)               6.8±1.1                  6.5±1.2                  −0.27±0.06   \<0.001   7.1±1.4     7.1±1.3     −0.01±0.09   0.914     0.016
  Weight-adjusted SMI         0.37±0.05                0.37±0.05                0.00±0.01    0.708     0.36±0.06   0.37±0.06   0.01±0.01    \<0.001   0.003
  Lean body mass (kg)         23.3±5.3                 22.7±5.2                 −0.58±0.15   \<0.001   25.2±6.8    25.4±6.6    −0.54±0.52   0.532     0.210
  Right arm (kg)              2.3±0.6                  2.2±0.6                  −0.09±0.02   \<0.001   2.4±0.9     2.5±0.8     0.04±0.03    0.316     0.003
  Left arm (kg)               2.2±0.6                  2.2±0.6                  −0.08±0.02   \<0.001   2.4±0.9     2.5±0.9     0.06±0.03    0.122     0.001
  Trunk (kg)                  19.4±4.1                 19.0±4.1                 −0.43±0.12   \<0.001   20.6±5.4    20.9±5.3    0.28±0.16    0.170     0.001
  Right leg (kg)              6.6±1.6                  6.4±1.8                  −0.22±0.07   0.003     7.3±2.1     7.2±2.0     −0.05±0.09   0.591     0.136
  Left leg (kg)               6.6±1.6                  6.2±1.8                  −0.32±0.13   0.040     7.3±2.0     7.2±2.0     −0.07±0.17   0.426     0.250
  Body fat mass (kg)          20.4±9.9                 20.1±1.8                 −0.30±0.24   0.282     23.7±13.3   22.7±13.3   −1.01±0.32   \<0.001   0.039

Data are mean±SD. Change was defined as the difference of SMI between the beginning and end of the hospitalization.

\*P values are evaluated by paired t-test.

†P values are evaluated by Mann-Whitney U test.

SMI, skeletal muscle mass index.

In patients without exercise habit, the change in SMI of the patients with radio calisthenics tended to be lesser than that of patients without (−0.07±0.26 kg/m^2^ vs −0.25±0.34 kg/m^2^, p=0.168). In addition, in patients with exercise habit, the change in SMI of the patients with radio calisthenics was lesser than that of patients without (−0.12±0.33 kg/m^2^ vs −0.30±0.37 kg/m^2^, p=0.047).

There were no adverse effects related to the radio calisthenics, such as hypoglycemia, fall, fracture, and musculoskeletal pain.

Discussion {#s4}
==========

Our study showed clear effects of radio calisthenics on muscle mass in hospitalized patients with type 2 diabetes. The change of SMI was significantly lesser in radio calisthenics exercisers. Weights of both appendicular skeletal muscles and upper limb muscles increased in radio calisthenics exercisers. Our past experience demonstrated that muscle volume reduces due to long-term hospitalization. In fact, about 85% of patients who did not perform radio calisthenics showed reduced muscle mass during hospitalization in this study. As a part of the treatment for patients with type 2 diabetes during hospitalization, it was necessary to determine an easy exercise therapy that could prevent reduction of skeletal muscle mass. In this study, we revealed that performing the radio calisthenics twice a day could help in maintaining the muscle mass of hospitalized patients.

Our study showed that radio calisthenics is associated with maintaining muscle mass in hospitalized patients with type 2 diabetes and helps in moving the appendicular skeletal muscles effectively. Exercise training improves insulin sensitivity in the skeletal muscles by increasing the muscular glucose uptake.[@R9] Despite the simple procedures, it guarantees an exercise intensity of 4.5 METs and improves the glycemic control among patients with type 2 diabetes. Moreover, maintaining muscle mass prevents the deterioration of type 2 diabetes and the development of sarcopenia.[@R1] In addition, there were no adverse effects related to the radio calisthenics.

A previous report revealed that people, who perform radio calisthenics more than 5 days a week for more than 3 years, were superior in muscle mass quantity, index of subclinical atherosclerosis and lung function compared with general population.[@R28] Moreover, a previous study reported that radio calisthenics is the second exercise therapy followed by walking in Japanese outpatients with diabetes,[@R29] and radio calisthenics is very popular in Japan. We also revealed that radio calisthenics is useful for preventing reduction of skeletal muscle mass more in patients with exercise habit than in patients without. This might be because many patients with exercise habit performed walking in Japan,[@R29] one of the aerobic exercises; thus the patients with exercise habit can prevent decreasing SMI through obtaining both aerobic and resistance training effect.

Additionally, we could not demonstrate the association between the performance of radio calisthenics and improvement of glucose control. In this study, there was no significant difference between radio calisthenics and glucose control (37.0±69.6 mg/dL vs 31.3±52.2 mg/dL, p=0.784). A possible explanation is that pharmacotherapy is a major factor affecting blood glucose, especially during hospitalization, and thus no significant difference in blood glucose improvement was detected between two groups. Additionally, because radio calisthenics is mainly resistance training, there is a possibility that radio calisthenics did not contribute to improving short-term glycemic control during hospitalization.

There was no incidence of hypoglycemia associated with radio calisthenics in this study. However, during hospitalization, the blood glucose of the patients has been checked at least four times a day, before every meal and at bedtime, and we have checked them every day and adjusted insulin and oral antidiabetic drugs appropriately in order to prevent hypoglycemia, which might result in the finding.

There are several limitations to this study that have to be mentioned. First, this study was not a randomized controlled trial, but a retrospective cohort study. Therefore, some bias might exist. To clarify the effect of radio calisthenics on skeletal muscle mass, further studies, especially randomized controlled trials, would be needed. Second, the study population consisted only of Japanese. Thus, it is unclear whether the same results can be obtained in the Western population with different physiques. Third, the sample size was not large. Fourth, we did not follow-up the data of body composition after discharge. Therefore, the long-term effect of radio calisthenics remains unclear. Additionally, we could not demonstrate the association between the performance of radio calisthenics and improvement of glucose control. In this study, there was no significant difference between radio calisthenics and glucose control (37.0±69.6 mg/dL vs 31.3±52.2 mg/dL, p=0.784). In this point, further studies would be needed as well. Lastly, because we used data using a body composition analyzer with a multifrequency impedance, change of body water balance might affect this result.

In conclusion, our study showed the effect of radio calisthenics on skeletal muscle mass in patients with type 2 diabetes. In order to elucidate this causal relationship, further accurate analyses, such as a randomized controlled trial, will be required.
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